Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Low Volume + High Share Control

<< Previous

Bullboard Posts

Next >>

Comment by Domino55on Feb 25, 2021 3:52pm

115 Views

Post# 32660780

RE:RE:RE:Low Volume + High Share Control

MM-That logic seems straightforward enough. I have some questions:

why do you think that the company valued Dialco at only 60 cents in their December presentation?

why do you think that the recent clinic DIMI FDA approval and recent IDE approval have been so damaging to the share price?

do you think that there will be more valuation integrity in the share price as Dr Kellum gets acquainted with his role?

TIA

<< Previous

Bullboard Posts

Next >>

B2Gold stock buckles under news of labour strike in Mali